Cargando…
p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
The aim of the study was to determine the incidence of p53 alterations by mutation, deletion or inactivation by mdm2 or human papillomavirus (HPV) infection in recurrent squamous cell cancer of the head and neck (SCCHN) refractory to radiotherapy. Twenty-two tumours were studied. The p53 status of e...
Autores principales: | Ganly, I, Soutar, D S, Brown, R, Kaye, S B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363290/ https://www.ncbi.nlm.nih.gov/pubmed/10646894 http://dx.doi.org/10.1054/bjoc.1999.0932 |
Ejemplares similares
-
Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53
por: Ohnishi, K, et al.
Publicado: (2000) -
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer
por: Yamazaki, Hideya, et al.
Publicado: (2016) -
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
por: Pivot, X, et al.
Publicado: (2001) -
High prevalence of p16 genetic alterations in head and neck tumours
por: Miracca, E C, et al.
Publicado: (1999) -
Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy
por: Murakami, Naoya, et al.
Publicado: (2019)